References
- Howard M, O'Garra A, Ishida H, de Waal Malefyt R, de Vries J. Biological properties of interleukin-10. J Clin Immunol 1992;12:239–47.
- De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209–20.
- De Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, Te Velde A, Figdor C, et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen- specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility com-plex expression. J Exp Med 1991;174:915–24.
- Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the Interleukin-10 gene promoter. Eur J Immunogenet 1997;24:1–8.
- Johnson PM, Faulk WP. Rheumatoid factor: its nature, speci-ficity and production in rheumatoid arthritis. Clin Immunol Immunopathol 1976;6:414–30.
- Pascual V, Victor K, Randen I, Thompson K, Natvig JB, Capra JD. IgM rheumatoid factors in patients with rheumatoid arthritis derive from a diverse array of germline immunoglobu-lin genes and display little evidence of somatic variation. J Rheumatol 1992;19:50–3.
- Van Zeben D, Breedveld FC. Prognostic factors in rheumatoid arthritis. J Rheumatol 1996;23:31–3.
- Defrance T, Vanbervliet B, Briere F, Durand I, Rousset F, Banchereau J. Interleukin 10 and transforming growth factor beta cooperate to induce anti- CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med 1992;175:671–82.
- Llorente L, Richaud-Patin Y, Fior R, Alcocer-Varela J, Wijdenes J, Fourrier BM, et al. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren's syn-drome, and systemic lupus erythematosus: A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum 1994;37:1647–55.
- Isomäki P, Luukkainen R, Saario R, Toivanen P, Punnonen J. Interleukin-10 functions as an antiinflammatory cytokine in rheumatoid synovium. Arthritis Rheum 1996;39: 386–95.
- Perez L, Orte J, Brieva JA. Terminal differentiation of sponta-neous rheumatoid factor-secreting cells from rheumatoid arthritis patients depends on endogenous interleukin-10. Arthritis Rheum 1995;38: 1771–6.
- Silman AJ, MacGregor AJ, Thomson W, Holligan S, Carthy D, Farhan A, et al. Twin concordance rates for rheumatoid arthri-tis: Results from a nationwide study. Br J Rheumatol 1993;32:903–7.
- Mageed RA, Kirwan JR, Holborow EJ. Localization of circu-lating immune complexes from patients with rheumatoid arthritis in murine spleen germinal centres. Scand J Immunol 1991; 34:323–31.
- Otten HG, Daha MR, Van Laar JM, De Rooy HH, Breedveld FC. Subclass distribution and size of human IgA rheumatoid factor at mucosal and nonmucosal sites. Arthritis Rheum 1991;34:831–9.
- MacGregor AJ, 011ier WER, Venkovsky J, Mageed RA, Carthy D, Silman AJ. Rheumatoid factor isotypes in monozygotic and dizygotic twins discordant for rheumatoid arthritis. J Rheuma-tol 1995;22:2203–7.